Trials / Unknown
UnknownNCT02047058
Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
A Multi-center, Prospective, Observational Study of Analysis of Q Cell Markers in Patients With Newly Diagnosed Primary Glioblastoma (Phase IV)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Q cells separated from the glioma sample are determinants in treatment response and prognosis of glioma patients
Detailed description
The unique markers of Qcell were screened using the method of genomics and proteomics, then these markers will be qualitatively and quantitatively evaluated in glioblastoma patients by comparing their relationship with overrall survival/progression-free survival and treatment response.
Conditions
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-12-01
- Completion
- 2017-03-01
- First posted
- 2014-01-28
- Last updated
- 2014-01-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02047058. Inclusion in this directory is not an endorsement.